glp-1 amgen ADA: talks Repatha, hurdles as obesity plan advances Amgen Partnership Expands GLP-1 Insurance

Gln 24 Substituting GLP-1 Ala 30 with Gln decreases the affinity (IC 50 : 0.27 nM1.4 nM) but increases activity (EC 50 : 2.6 nM0.5 nM)

Obesity 33(3):452462 [DOI] [PMC free article] [PubMed] [Google Scholar] 81.Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S et al (2023) Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Lets walk through why this happens and what we can do about it, keeping everything evidence-based and tailored to your goals

Maida et al

Initial weight loss typically occurs within the first month, with ongoing, steady progress over the following months